Global Whole Exome Sequencing Market Size, Manufacturers, Opportunities and Forecast to 2030

Global Whole Exome Sequencing Market Size, Manufacturers, Opportunities and Forecast to 2030


Summary

Exome sequencing is a capture based method developed to identify variants in the coding region of genes which affect protein function. While exome capture methods using PCR, hybrid capture and molecular inversion probes exist, the most common and efficient strategies are in-solution capture methods. In-solution capture utilizes pools of oligonucleotides or probes bound to magnetic beads, whose sequence has been designed to hybridize to exon regions. After binding to genomic DNA, these probes are pulled down and washed, allowing exon regions to be selectively sequenced.
While there are approximately 180,000 exons in the human genome, constituting less than 2% of total sequence, the exome contains ~80-90% of known disease causing variants making it a cost-effective alternative to whole genome sequencing. When performing exome-seq, users should not only consider average on-target coverage but also the local coverage of particular sites of interest. When choosing between exome and whole genome sequencing (WGS), consider that exome sequencing has the advantage that oligonucleotides are designed to particular genomic regions where typical coverage with WGS is not enough for SNP calling. It is also more affordable enabling the analysis of more individuals and populations. With WGS, you can detect variants in regions not covered by exome capture allowing or the identification of structural and non-coding variants associated with disease.
According to APO Research, The global Whole Exome Sequencing market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Whole Exome Sequencing is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Whole Exome Sequencing is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Whole Exome Sequencing is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Whole Exome Sequencing include Illumina, Thermo Fisher, Roche, Angilent, Eurofins, Sengenics, Ambry, Macrogen and BGI, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Whole Exome Sequencing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Whole Exome Sequencing.
The Whole Exome Sequencing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Whole Exome Sequencing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Illumina
Thermo Fisher
Roche
Angilent
Eurofins
Sengenics
Ambry
Macrogen
BGI
Novo Gene
Whole Exome Sequencing segment by Type

Agilent HaloPlex
Agilent SureSelect
Agilent SureSelect QXT
Illumina TruSeq Exome
Roche Nimblegen SeqCap
MYcroarray MYbaits
Whole Exome Sequencing segment by Application

Correlation Research of Normal Human
Mendelian Disease and Rare Syndrome Gene Discovery
The Research of Complex Diseases
Mouse Exome Sequencing
Whole Exome Sequencing Segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Whole Exome Sequencing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Whole Exome Sequencing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Whole Exome Sequencing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2019-2024, 2025-2030). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Whole Exome Sequencing companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.3 Global Whole Exome Sequencing Market Size Overview by Region 2019 VS 2023 VS 2030
1.4 Global Whole Exome Sequencing Market Size by Region (2019-2030)
1.4.1 Global Whole Exome Sequencing Market Size by Region (2019-2024)
1.4.2 Global Whole Exome Sequencing Market Size by Region (2025-2030)
1.5 Key Regions Whole Exome Sequencing Market Size (2019-2030)
1.5.1 North America Whole Exome Sequencing Market Size Growth Rate (2019-2030)
1.5.2 Europe Whole Exome Sequencing Market Size Growth Rate (2019-2030)
1.5.3 Asia-Pacific Whole Exome Sequencing Market Size Growth Rate (2019-2030)
1.5.4 Latin America Whole Exome Sequencing Market Size Growth Rate (2019-2030)
1.5.5 Middle East & Africa Whole Exome Sequencing Market Size Growth Rate (2019-2030)
2 Whole Exome Sequencing Market by Type
2.1 Type Introduction
2.1.1 Agilent HaloPlex
2.1.2 Agilent SureSelect
2.1.3 Agilent SureSelect QXT
2.1.4 Illumina TruSeq Exome
2.1.5 Roche Nimblegen SeqCap
2.1.6 MYcroarray MYbaits
2.2 Global Whole Exome Sequencing Market Size by Type
2.2.1 Global Whole Exome Sequencing Market Size Overview by Type (2019-2030)
2.2.2 Global Whole Exome Sequencing Historic Market Size Review by Type (2019-2024)
2.2.3 Global Whole Exome Sequencing Market Size Forecasted by Type (2025-2030)
2.3 Global Whole Exome Sequencing Market Size by Regions
2.3.1 North America Whole Exome Sequencing Market Size Breakdown by Type (2019-2024)
2.3.2 Europe Whole Exome Sequencing Market Size Breakdown by Type (2019-2024)
2.3.3 Asia-Pacific Whole Exome Sequencing Market Size Breakdown by Type (2019-2024)
2.3.4 Latin America Whole Exome Sequencing Market Size Breakdown by Type (2019-2024)
2.3.5 Middle East and Africa Whole Exome Sequencing Market Size Breakdown by Type (2019-2024)
3 Whole Exome Sequencing Market by Application
3.1 Type Introduction
3.1.1 Correlation Research of Normal Human
3.1.2 Mendelian Disease and Rare Syndrome Gene Discovery
3.1.3 The Research of Complex Diseases
3.1.4 Mouse Exome Sequencing
3.2 Global Whole Exome Sequencing Market Size by Application
3.2.1 Global Whole Exome Sequencing Market Size Overview by Application (2019-2030)
3.2.2 Global Whole Exome Sequencing Historic Market Size Review by Application (2019-2024)
3.2.3 Global Whole Exome Sequencing Market Size Forecasted by Application (2025-2030)
3.3 Global Whole Exome Sequencing Market Size by Regions
3.3.1 North America Whole Exome Sequencing Market Size Breakdown by Application (2019-2024)
3.3.2 Europe Whole Exome Sequencing Market Size Breakdown by Application (2019-2024)
3.3.3 Asia-Pacific Whole Exome Sequencing Market Size Breakdown by Application (2019-2024)
3.3.4 Latin America Whole Exome Sequencing Market Size Breakdown by Application (2019-2024)
3.3.5 Middle East and Africa Whole Exome Sequencing Market Size Breakdown by Application (2019-2024)
4 Global Market Dynamics
4.1 Whole Exome Sequencing Industry Trends
4.2 Whole Exome Sequencing Industry Drivers
4.3 Whole Exome Sequencing Industry Opportunities and Challenges
4.4 Whole Exome Sequencing Industry Restraints
5 Competitive Insights by Company
5.1 Global Top Players by Whole Exome Sequencing Revenue (2019-2024)
5.2 Global Whole Exome Sequencing Industry Company Ranking, 2022 VS 2023 VS 2024
5.3 Global Whole Exome Sequencing Key Company Headquarters & Area Served
5.4 Global Whole Exome Sequencing Company, Product Type & Application
5.5 Global Whole Exome Sequencing Company Commercialization Time
5.6 Market Competitive Analysis
5.6.1 Global Whole Exome Sequencing Market CR5 and HHI
5.6.2 Global Top 5 and 10 Whole Exome Sequencing Players Market Share by Revenue in 2023
5.6.3 2023 Whole Exome Sequencing Tier 1, Tier 2, and Tier 3
6 Company Profiles
6.1 Illumina
6.1.1 Illumina Comapny Information
6.1.2 Illumina Business Overview
6.1.3 Illumina Whole Exome Sequencing Revenue, Global Share and Gross Margin (2019-2024)
6.1.4 Illumina Whole Exome Sequencing Product Portfolio
6.1.5 Illumina Recent Developments
6.2 Thermo Fisher
6.2.1 Thermo Fisher Comapny Information
6.2.2 Thermo Fisher Business Overview
6.2.3 Thermo Fisher Whole Exome Sequencing Revenue, Global Share and Gross Margin (2019-2024)
6.2.4 Thermo Fisher Whole Exome Sequencing Product Portfolio
6.2.5 Thermo Fisher Recent Developments
6.3 Roche
6.3.1 Roche Comapny Information
6.3.2 Roche Business Overview
6.3.3 Roche Whole Exome Sequencing Revenue, Global Share and Gross Margin (2019-2024)
6.3.4 Roche Whole Exome Sequencing Product Portfolio
6.3.5 Roche Recent Developments
6.4 Angilent
6.4.1 Angilent Comapny Information
6.4.2 Angilent Business Overview
6.4.3 Angilent Whole Exome Sequencing Revenue, Global Share and Gross Margin (2019-2024)
6.4.4 Angilent Whole Exome Sequencing Product Portfolio
6.4.5 Angilent Recent Developments
6.5 Eurofins
6.5.1 Eurofins Comapny Information
6.5.2 Eurofins Business Overview
6.5.3 Eurofins Whole Exome Sequencing Revenue, Global Share and Gross Margin (2019-2024)
6.5.4 Eurofins Whole Exome Sequencing Product Portfolio
6.5.5 Eurofins Recent Developments
6.6 Sengenics
6.6.1 Sengenics Comapny Information
6.6.2 Sengenics Business Overview
6.6.3 Sengenics Whole Exome Sequencing Revenue, Global Share and Gross Margin (2019-2024)
6.6.4 Sengenics Whole Exome Sequencing Product Portfolio
6.6.5 Sengenics Recent Developments
6.7 Ambry
6.7.1 Ambry Comapny Information
6.7.2 Ambry Business Overview
6.7.3 Ambry Whole Exome Sequencing Revenue, Global Share and Gross Margin (2019-2024)
6.7.4 Ambry Whole Exome Sequencing Product Portfolio
6.7.5 Ambry Recent Developments
6.8 Macrogen
6.8.1 Macrogen Comapny Information
6.8.2 Macrogen Business Overview
6.8.3 Macrogen Whole Exome Sequencing Revenue, Global Share and Gross Margin (2019-2024)
6.8.4 Macrogen Whole Exome Sequencing Product Portfolio
6.8.5 Macrogen Recent Developments
6.9 BGI
6.9.1 BGI Comapny Information
6.9.2 BGI Business Overview
6.9.3 BGI Whole Exome Sequencing Revenue, Global Share and Gross Margin (2019-2024)
6.9.4 BGI Whole Exome Sequencing Product Portfolio
6.9.5 BGI Recent Developments
6.10 Novo Gene
6.10.1 Novo Gene Comapny Information
6.10.2 Novo Gene Business Overview
6.10.3 Novo Gene Whole Exome Sequencing Revenue, Global Share and Gross Margin (2019-2024)
6.10.4 Novo Gene Whole Exome Sequencing Product Portfolio
6.10.5 Novo Gene Recent Developments
7 North America
7.1 North America Whole Exome Sequencing Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2 North America Whole Exome Sequencing Market Size by Country (2019-2024)
7.3 North America Whole Exome Sequencing Market Size Forecast by Country (2025-2030)
8 Europe
8.1 Europe Whole Exome Sequencing Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2 Europe Whole Exome Sequencing Market Size by Country (2019-2024)
8.3 Europe Whole Exome Sequencing Market Size Forecast by Country (2025-2030)
9 Asia-Pacific
9.1 Asia-Pacific Whole Exome Sequencing Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2 Asia-Pacific Whole Exome Sequencing Market Size by Country (2019-2024)
9.3 Asia-Pacific Whole Exome Sequencing Market Size Forecast by Country (2025-2030)
10 Latin America
10.1 Latin America Whole Exome Sequencing Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2 Latin America Whole Exome Sequencing Market Size by Country (2019-2024)
10.3 Latin America Whole Exome Sequencing Market Size Forecast by Country (2025-2030)
11 Middle East & Africa
11.1 Middle East & Africa Whole Exome Sequencing Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2 Middle East & Africa Whole Exome Sequencing Market Size by Country (2019-2024)
11.3 Middle East & Africa Whole Exome Sequencing Market Size Forecast by Country (2025-2030)
12 Concluding Insights
13 Appendix
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings